AbCellera Biologics Inc (ABCL) last year’s performance of -50.33% is a clear signal for an entertaining trading season.
On Monday, AbCellera Biologics Inc (NASDAQ: ABCL) opened lower -3.46% from the last session, before settling in for the closing price of $2.31. Price fluctuations